American Society of Clinical Oncology

SHERPA: White

People

  1. Janjigian
    Janjigian
  2. Ilson
    Ilson
  3. Kelsen
    Kelsen
  4. Ku
    Ku
  5. Schultz
    Schultz
  6. Strong
    Strong
  7. Maron
    Maron
  8. Solit
    Solit
  9. Capanu
    Capanu
  10. Chou
    Chou

Groups

  1. Department of Medicine (130)
  2. Gastrointestinal Oncology Service (130)
  3. Solid Tumor Oncology Division (130)
  4. Center for Pancreatic Cancer Research (63)
  5. Epidemiology and Biostatistics (51)
  6. Hematologic Malignancies, Division of (51)
  7. Survivorship Research (50)
  8. Surgery (45)
  9. GSK Faculty (38)
  10. Biostatistics Service (36)
Search Within
  1. "Yelena Janjigian"
Formats
  1. Meeting Abstract (116)
  2. Journal Article (12)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Department of Medicine (130)
  2. Gastrointestinal Oncology Service (130)
  3. Solid Tumor Oncology Division (130)
  4. Center for Pancreatic Cancer Research (63)
  5. Epidemiology and Biostatistics (51)
  6. Hematologic Malignancies, Division of (51)

More Groups

People
  1. Yelena Janjigian (130)
  2. David Ilson (54)
  3. Geoffrey Ku (45)
  4. David Kelsen (44)
  5. Marinela Capanu (31)
  6. Laura Tang (27)

More People

Years
  1. 2023 (14)
  2. 2022 (8)
  3. 2021 (19)
  4. 2020 (8)
  5. 2019 (10)
  6. 2018 (13)

More Years

Publications
  1. Journal of Clinical Oncology (125)
  2. JCO Precision Oncology (3)
  3. American Society of Clinical Oncology Educational Book (1)
  4. JCO Clinical Cancer Informatics (1)

Results (130)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoTree: A cancer classification system for precision oncology
    Journal Article

    Kundra, R.; Zhang, H.; Sheridan, R.; Sirintrapun, S. J.; Wang, A.; Ochoa, A.; Wilson, M.; Gross, B.; Sun, Y.; Madupuri, R.; more...
    JCO Clinical Cancer Informatics (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors
    Meeting Abstract

    Bendell, J. C.; Strauss, J. F.; Fakih, M.; McRee, A. J.; Hendifar, A. E.; Rosen, L. S.; Cercek, A.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Chemotherapy and COVID-19 outcomes in patients with cancer
    Journal Article

    Jee, J.; Foote, M. B.; Lumish, M.; Stonestrom, A. J.; Wills, B.; Narendra, V.; Avutu, V.; Murciano-Goroff, Y. R.; Chan, J. E.; Derkach, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma
    Meeting Abstract

    Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction cancer (mG/GEJc): A double-blind, randomized, placebo-controlled phase III study
    Meeting Abstract

    Chung, H. C.; Bang, Y. J.; Fuchs, C. S.; Qin, S.; Satoh, T.; Shitara, K.; Tabernero, J.; Van Cutsem, E.; Alsina, M.; Cao, Z. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic correlates of extreme pathologic response following neoadjuvant chemotherapy in locally advanced gastric cancer to reveal distinct vulnerabilities
    Meeting Abstract

    Datta, J.; Walch, H. S.; Russo, A.; Chatila, W. K.; Vos, E.; Bhanot, U.; Janjigian, Y. Y.; Schultz, N.; Tang, L. H.; Strong, V. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Current and future aspects of immunotherapy for esophageal and gastric malignancies
    Review

    De Mello, R. A.; Lordick, F.; Muro, K.; Janjigian, Y. Y.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save